Imugene Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported net loss was AUD 68.71 million compared to AUD 17.39 million a year ago. Basic loss per share from continuing operations was AUD 0.01 compared to AUD 0.0028 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.079 AUD | -4.82% | +11.27% | -28.18% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.18% | 377M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IMU Stock
- News Imugene Limited
- Imugene Limited Reports Earnings Results for the Half Year Ended December 31, 2023